The direct primary care revolution
A small but growing group of primary care doctors are saying, "no more" to EHR requirements, useless quality measures, and indecipherable bills. More
A small but growing group of primary care doctors are saying, "no more" to EHR requirements, useless quality measures, and indecipherable bills. More
Ever wonder why you can't get a straight answer about how much a test or procedure in the hospital? This new report has answers. More
American women are still getting too many mammograms. Despite recommendations from the US Preventive Services Task Force and the American Cancer Society against routine screening for breast cancer before age 50, the rates of mammogram screening have not changed significantly in the past ten years. In a recent JAMA Clinical Update, Dr. Nancy Keating and […] More
For Randi Oster, the hardest part of her father's cancer wasn't getting him through treatment. It was getting his doctors to listen to what he wanted. More
When it comes to measuring quality, there is a huge disconnect between payers and physicians. A recent analysis in the New England Journal of Medicine lends support to the physicians' side of the issue. More
Gina Kolata misrepresents the debate on tPA for strokes by painting the issue as evidence versus belief. More
Recent conflicts of interest in medicine and health policy you probably missed... More
A closer look at the hundreds of millions that pharma spends on payments to physicians. More
A closer look at the hundreds of millions that pharma spends on payments to physicians. More
How can we increase access to primary care in underserved areas? How about meeting patients where they are? More
A study in The BMJ shows that overdiagnosis research is growing but discrepancies in definitions and measurement complicate the evidence. More
Not only does too much cancer screening lead to false positives and overtreatment, it can also skew our data. More
Opioids aren't the only drug being dangerously overprescribed... More
Why the new lower blood pressure target could be harmful to patients... More
Does value-based care stand a chance against the fee-for-service Goliath? More
Every day is Halloween for pharma marketers... More
Medical overuse is just as much a problem in children's health care as it is for adults, so why isn't there more recognition of this issue? More
Fee-for-service drives overuse and high costs, but what's the alternative? Maryland may have the answer. More
Researchers and advocates are up in arms over a new review of Hepatitis C treatments. But look who's funding each side... More
From industry payments to kickbacks, corruption is everywhere in health care. And it comes at a high cost to patient safety. More